Inter- and intra-chromosomal modulators of the APOE e2 and e4 effects on the Alzheimer's disease risk

被引:5
|
作者
Nazarian, Alireza [1 ]
Philipp, Ian [1 ]
Culminskaya, Irina [1 ]
He, Liang [1 ]
Kulminski, Alexander M. [1 ]
机构
[1] Duke Univ, Biodemog Aging Res Unit, Social Sci Res Inst, Erwin Mill Bldg,2024 W Main St, Durham, NC 27705 USA
关键词
Dementia; Aging; LD; Cox regression; Compound genotype; Genetic heterogeneity; E ALLELE EPSILON-4; APOLIPOPROTEIN-E; LINKAGE-DISEQUILIBRIUM; NATIONAL INSTITUTE; ASSOCIATION; GENE; GWAS; LSD1; AGE; DISCOVERY;
D O I
10.1007/s11357-022-00617-0
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
The mechanisms of incomplete penetrance of risk-modifying impacts of apolipoprotein E (APOE) epsilon 2 and epsilon 4 alleles on Alzheimer's disease (AD) have not been fully understood. We performed genome-wide analysis of differences in linkage disequilibrium (LD) patterns between 6,136 AD-affected and 10,555 AD-unaffected subjects from five independent studies to explore whether the association of the APOE epsilon 2 allele (encoded by rs7412 polymorphism) and epsilon 4 allele (encoded by rs429358 polymorphism) with AD was modulated by autosomal polymorphisms. The LD analysis identified 24 (mostly inter-chromosomal) and 57 (primarily intra-chromosomal) autosomal polymorphisms with significant differences in LD with either rs7412 or rs429358, respectively, between AD-affected and AD-unaffected subjects, indicating their potential modulatory roles. Our Cox regression analysis showed that minor alleles of four inter-chromosomal and ten intra-chromosomal polymorphisms exerted significant modulating effects on the epsilon 2- and epsilon 4-associated AD risks, respectively, and identified epsilon 2-independent (rs2884183 polymorphism, 11q22.3) and epsilon 4-independent (rs483082 polymorphism, 19q13.32) associations with AD. Our functional analysis highlighted epsilon 2- and/or epsilon 4-linked processes affecting the lipid and lipoprotein metabolism and cell junction organization which may contribute to AD pathogenesis. These findings provide insights into the epsilon 2- and epsilon 4-associated mechanisms of AD pathogenesis, underlying their incomplete penetrance.
引用
收藏
页码:233 / 247
页数:15
相关论文
共 50 条
  • [31] ApoE e4 selectively affects memory and is not moderated by symptom duration or age in patients with Alzheimer's disease
    Smerz, JM
    Wagner, MT
    ARCHIVES OF CLINICAL NEUROPSYCHOLOGY, 2005, 20 (07) : 853 - 854
  • [32] Amygdala: the region most affected by the APOE e4 effect on tau deposition in individuals with Alzheimer's disease
    Li, Yanxiao
    Ge, Qi
    Yan, Shaozhen
    Lu, Jie
    Wang, Xiuying
    Zhou, Yun
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64
  • [33] Apolipoprotein E and Alzheimer's disease: The protective effects of ApoE2 and E3
    Rebeck, G. William
    Kindy, Mark
    Ladu, Mary Jo
    JOURNAL OF ALZHEIMERS DISEASE, 2002, 4 (03) : 145 - 154
  • [34] Detrimental effects of apolipoprotein E4: Potential therapeutic targets in Alzheimer's disease
    Mahley, Robert W.
    Huang, Yadong
    Weisgraber, Karl H.
    CURRENT ALZHEIMER RESEARCH, 2007, 4 (05) : 537 - 540
  • [35] The beneficial effects of vitamin E and selegiline in a controlled trial in Alzheimer's Disease are independent of the apolipoprotein E e4 allele
    Galasko, DR
    Sano, M
    Berg, J
    Thomas, RG
    Grundman, M
    Thal, LJ
    NEUROLOGY, 1999, 52 (06) : A397 - A397
  • [36] Protein phosphatase 2A and complement component 4 are linked to the protective effect of APOE e2 for Alzheimer's disease
    Jun, Gyungah R.
    You, Yang
    Zhu, Congcong
    Meng, Gaoyuan
    Chung, Jaeyoon
    Panitch, Rebecca
    Hu, Junming
    Xia, Weiming
    Bennett, David A.
    Foroud, Tatiana M.
    Wang, Li-San
    Haines, Jonathan L.
    Mayeux, Richard
    Pericak-Vance, Margaret A.
    Schellenberg, Gerard D.
    Au, Rhoda
    Lunetta, Kathryn L.
    Ikezu, Tsuneya
    Stein, Thor D.
    Farrer, Lindsay A.
    ALZHEIMERS & DEMENTIA, 2022, 18 (11) : 2042 - 2054
  • [37] Apolipoprotein E4, inhibitory network dysfunction, and Alzheimer's disease
    Najm, Ramsey
    Jones, Emily A.
    Huang, Yadong
    MOLECULAR NEURODEGENERATION, 2019, 14 (1)
  • [38] The current status of Apo E4 as a risk factor for Alzheimer's disease: An epidemiological perspective
    Ritchie, K
    Dupuy, AM
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 1999, 14 (09) : 695 - 700
  • [39] Neuropsychological and anatomical correlates of E4 in Alzheimer's disease.
    Earl, HD
    Olsen, J
    Bigler, ED
    ARCHIVES OF CLINICAL NEUROPSYCHOLOGY, 1999, 14 (08) : 619 - 620
  • [40] Apolipoprotein E4 allele and ribosomal genes in Alzheimer's disease
    Tavares, WM
    Sperança, MA
    de Labio, RW
    Peres, CA
    Okamoto, IH
    Bertolucci, PHF
    Smith, MD
    Payao, SLM
    JOURNAL OF ALZHEIMERS DISEASE, 2004, 6 (04) : 391 - 395